Manhattan, NY - Pfizer Inc. said that it plans to cut its sales staff by 20% nationwide as part of its ongoing restructuring efforts.
The Manhattan-based drug maker said last month that it would undertake a comprehensive review of all of its operations.
Earlier this year, Pfizer said it would cut about 270 jobs at its Brooklyn manufacturing plant, which makes many of the products that will face generic competition as their patent exclusivity runs out. “The changes we are making today will better align our sales organization to our overall customer and business needs,” said Pfizer Chief Executive Jeffrey Kindler in a statement.
Tuesday, November 28, 2006
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment